135 related articles for article (PubMed ID: 29697018)
1. A crystallographic and theoretical study of an (E)-2-Hydroxyiminoethanone derivative: prediction of cyclooxygenase inhibition selectivity of stilbenoids by MM-PBSA and the role of atomic charge.
Hosseini Balef SS; Chippindale AM; Irannejad H
J Biomol Struct Dyn; 2019 Apr; 37(6):1555-1566. PubMed ID: 29697018
[TBL] [Abstract][Full Text] [Related]
2. Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs.
Pouplana R; Lozano JJ; Pérez C; Ruiz J
J Comput Aided Mol Des; 2002 Oct; 16(10):683-709. PubMed ID: 12650588
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase.
Llorens O; Perez JJ; Palomer A; Mauleon D
Bioorg Med Chem Lett; 1999 Oct; 9(19):2779-84. PubMed ID: 10522690
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory mode of 1,5-diarylpyrazole derivatives against cyclooxygenase-2 and cyclooxygenase-1: molecular docking and 3D QSAR analyses.
Liu H; Huang X; Shen J; Luo X; Li M; Xiong B; Chen G; Shen J; Yang Y; Jiang H; Chen K
J Med Chem; 2002 Oct; 45(22):4816-27. PubMed ID: 12383007
[TBL] [Abstract][Full Text] [Related]
5. Free energy perturbation approach to the critical assessment of selective cyclooxygenase-2 inhibitors.
Park H; Lee S
J Comput Aided Mol Des; 2005 Jan; 19(1):17-31. PubMed ID: 16059664
[TBL] [Abstract][Full Text] [Related]
6. Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivatives.
Desiraju GR; Gopalakrishnan B; Jetti RK; Nagaraju A; Raveendra D; Sarma JA; Sobhia ME; Thilagavathi R
J Med Chem; 2002 Oct; 45(22):4847-57. PubMed ID: 12383010
[TBL] [Abstract][Full Text] [Related]
7. Flavonoids and stilbenoids with COX-1 and COX-2 inhibitory activity from Dracaena loureiri.
Likhitwitayawuid K; Sawasdee K; Kirtikara K
Planta Med; 2002 Sep; 68(9):841-3. PubMed ID: 12357401
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for selective inhibition of COX-2 by nimesulide.
Fabiola GF; Pattabhi V; Nagarajan K
Bioorg Med Chem; 1998 Dec; 6(12):2337-44. PubMed ID: 9925294
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and prostaglandin synthase inhibitory activity of new aromatic O-alkyloxime ethers substituted with methylsulfonamido or methylsulfonyl groups on their aliphatic portion.
Balsamo A; Mancini F; Milanese C; Orlandini E; Ortore G; Pinza M; Rapposelli S; Rossello A
Farmaco; 2003 Sep; 58(9):707-14. PubMed ID: 13679164
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship.
Murias M; Handler N; Erker T; Pleban K; Ecker G; Saiko P; Szekeres T; Jäger W
Bioorg Med Chem; 2004 Nov; 12(21):5571-8. PubMed ID: 15465334
[TBL] [Abstract][Full Text] [Related]
11. MM-PBSA and per-residue decomposition energy studies on 7-Phenyl-imidazoquinolin-4(5H)-one derivatives: Identification of crucial site points at microsomal prostaglandin E synthase-1 (mPGES-1) active site.
Gupta A; Chaudhary N; Aparoy P
Int J Biol Macromol; 2018 Nov; 119():352-359. PubMed ID: 30031079
[TBL] [Abstract][Full Text] [Related]
12. COX-2 selectivity and inflammatory processes.
van Ryn J; Trummlitz G; Pairet M
Curr Med Chem; 2000 Nov; 7(11):1145-61. PubMed ID: 11032964
[TBL] [Abstract][Full Text] [Related]
13. A CoMFA study of COX-2 inhibitors with receptor based alignment.
Datar PA; Coutinho EC
J Mol Graph Model; 2004 Dec; 23(3):239-51. PubMed ID: 15530820
[TBL] [Abstract][Full Text] [Related]
14. Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
Pouplana R; Lozano JJ; Ruiz J
J Mol Graph Model; 2002 Jan; 20(4):329-43. PubMed ID: 11858641
[TBL] [Abstract][Full Text] [Related]
15. Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site?
Soliva R; Almansa C; Kalko SG; Luque FJ; Orozco M
J Med Chem; 2003 Apr; 46(8):1372-82. PubMed ID: 12672237
[TBL] [Abstract][Full Text] [Related]
16. The structure of mammalian cyclooxygenases.
Garavito RM; Mulichak AM
Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066
[TBL] [Abstract][Full Text] [Related]
17. 1,5-Diarylpyrrole-3-acetic acids and esters as novel classes of potent and highly selective cyclooxygenase-2 inhibitors.
Biava M; Porretta GC; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Makovec F; Anzini M
J Med Chem; 2005 May; 48(9):3428-32. PubMed ID: 15857149
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence quenching analysis of the association and dissociation of a diarylheterocycle to cyclooxygenase-1 and cyclooxygenase-2: dynamic basis of cyclooxygenase-2 selectivity.
Lanzo CA; Sutin J; Rowlinson S; Talley J; Marnett LJ
Biochemistry; 2000 May; 39(20):6228-34. PubMed ID: 10821698
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition.
Limongelli V; Bonomi M; Marinelli L; Gervasio FL; Cavalli A; Novellino E; Parrinello M
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5411-6. PubMed ID: 20215464
[TBL] [Abstract][Full Text] [Related]
20. New pyrazole derivatives: Synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES.
Hassan GS; Abdel Rahman DE; Abdelmajeed EA; Refaey RH; Alaraby Salem M; Nissan YM
Eur J Med Chem; 2019 Jun; 171():332-342. PubMed ID: 30928706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
